Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 23, 2020

Primary Completion Date

December 10, 2020

Study Completion Date

December 10, 2020

Conditions

OsteoarthritisKnee

Interventions

DRUG

LNA043

Single intra-articular injection on Day 1

DRUG

Placebo

Single intra-articular injection on Day 1

Trial Locations (2)

Novartis Investigative Site, Shinjuku-ku

Novartis Investigative Site, Osaka